NCT01244971View on ClinicalTrials.gov

Exercise and Acarbose in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2004

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Acarbose

100mg, 3 times daily

BEHAVIORAL

Exercise

Moderate combined exercise, 50 minutes 3 times per week

OTHER

Exercise + Acarbose

See respective monotherapy description

Trial Locations (1)

17176

Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital, Stockholm

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Bayer

INDUSTRY

lead

Karolinska Institutet

OTHER

NCT01244971 - Exercise and Acarbose in Type 2 Diabetes | Biotech Hunter | Biotech Hunter